Ulrich et al. [6] reported that NSAID use by individuals with the wild type polymorphism of PTGS1 rs3842787 had a significantly reduced (Fig. 2A, OR = 0.70, 95% CI = 0.55–0.89) adenoma risk compared with non-NSAID users. Here, PTGS1 is linked to adenoma.